C Ribeiro Nogueira1, A Ramalho, E Lameu, C A Da Silva Franca, C David, E Accioly. 1. Vitamin A Research Group (Grupo de Pesquisa em Vitamina A-GPVA), Instituto de Nutrição Josué de Castro (INJC), Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil. carlafrancanut@yahoo.com.br
Abstract
INTRODUCTION: Sepsis is one of the main causes of mortality in patients in Intensive Care Units. As a result of the systemic inflammatory response and of the decrease of the aerobic metabolism in sepsis, the oxidative stress occurs. Vitamin A is recognized by the favorable effect that it exerts on the immune response to infections and antioxidant action. OBJECTIVE: To bring new elements for reviewing of the nutritional support addressed to critically ill patients with sepsis, with emphasis to vitamin A. METHODS: Critically ill patients with sepsis had circulating concentrations of retinol, beta-carotene, thiobarbituric acid-reactive substances (TBARS) and C-reactive protein (CRP) measured in Medicosurgical Intensive Care Unit in the city of Rio de Janeiro, Brazil. The patients were divided into two groups: patients who were receiving nutritional support and those without support. At the act of the patient's admission, APACHE II score was calculated. RESULTS: 46 patients were studied (with diet n = 24 and without diet n = 22). Reduced levels of retinol and beta-carotene were found in 65.2% and 73.9% of the patients, respectively. Among the patients who presented lower concentrations of CRP it was found higher beta-carotene inadequacy (64.8%) and 50% of retinol inadequacy. There was no significant difference as regards retinol, TBARS and APACHE II levels among the patients with and without nutritional support. However, higher levels of CRP (p = 0.001) and lower levels of serum beta-carotene (p = 0.047) were found in patients without nutritional support. CONCLUSIONS: Septic patients presented an important inadequacy of retinol and beta-carotene. The present study bring elements to the elaboration/review of the nutritional protocol directed to the group studied, especially as regards vitamin A intake.
INTRODUCTION:Sepsis is one of the main causes of mortality in patients in Intensive Care Units. As a result of the systemic inflammatory response and of the decrease of the aerobic metabolism in sepsis, the oxidative stress occurs. Vitamin A is recognized by the favorable effect that it exerts on the immune response to infections and antioxidant action. OBJECTIVE: To bring new elements for reviewing of the nutritional support addressed to critically illpatients with sepsis, with emphasis to vitamin A. METHODS:Critically illpatients with sepsis had circulating concentrations of retinol, beta-carotene, thiobarbituric acid-reactive substances (TBARS) and C-reactive protein (CRP) measured in Medicosurgical Intensive Care Unit in the city of Rio de Janeiro, Brazil. The patients were divided into two groups: patients who were receiving nutritional support and those without support. At the act of the patient's admission, APACHE II score was calculated. RESULTS: 46 patients were studied (with diet n = 24 and without diet n = 22). Reduced levels of retinol and beta-carotene were found in 65.2% and 73.9% of the patients, respectively. Among the patients who presented lower concentrations of CRP it was found higher beta-carotene inadequacy (64.8%) and 50% of retinol inadequacy. There was no significant difference as regards retinol, TBARS and APACHE II levels among the patients with and without nutritional support. However, higher levels of CRP (p = 0.001) and lower levels of serum beta-carotene (p = 0.047) were found in patients without nutritional support. CONCLUSIONS: Septic patients presented an important inadequacy of retinol and beta-carotene. The present study bring elements to the elaboration/review of the nutritional protocol directed to the group studied, especially as regards vitamin A intake.
Authors: Weiwen Chai; Shannon M Conroy; Gertraud Maskarinec; Adrian A Franke; Ian S Pagano; Robert V Cooney Journal: Nutr Res Date: 2010-04 Impact factor: 3.315
Authors: Andrea B Braun; Fiona K Gibbons; Augusto A Litonjua; Edward Giovannucci; Kenneth B Christopher Journal: Crit Care Med Date: 2012-01 Impact factor: 7.598
Authors: Iman A Khaled; Mervat S El-Ansary; Abeya F Saleh; Ola M Mahmoud; Emad A Baioumi; Heba A Bakr Journal: Mol Biol Rep Date: 2010-11-24 Impact factor: 2.316
Authors: Tilman E Klassert; Anja Hanisch; Julia Bräuer; Esther Klaile; Kerstin A Heyl; Michael K Mansour; Michael M Mansour; Jenny M Tam; Jatin M Vyas; Hortense Slevogt Journal: Med Microbiol Immunol Date: 2014-08-17 Impact factor: 3.402
Authors: Tilman E Klassert; Julia Bräuer; Martin Hölzer; Magdalena Stock; Konstantin Riege; Cristina Zubiría-Barrera; Mario M Müller; Silke Rummler; Christine Skerka; Manja Marz; Hortense Slevogt Journal: Sci Rep Date: 2017-01-17 Impact factor: 4.379